Business Description
Syntara Ltd
SIC : 2834
ISIN : AU0000312480
Total Employee Number:
93Compare
Compare
Traded in other countries / regions
SNT.AustraliaUUDA.GermanyPMXSF.USA IPO Date
2006-01-13Description
Pharmaxis Ltd is an Australian pharmaceutical company focused on drug development and specialty pharmaceuticals. It develops treatments for chronic inflammatory and fibrotic diseases, with a pipeline that has included candidates such as PXS-5505 for myelofibrosis and other cancers, and PXS-6302 for skin scarring. The company also manufactures and sells specialty pharmaceutical products, notably Bronchitol (mannitol) for cystic fibrosis and Aridol for asthma diagnosis, which are marketed in various international territories through partners. Pharmaxis generates revenue from product sales, licensing and milestone payments, and contract manufacturing at its Sydney facilities. Its research is based on amine oxidase chemistry, targeting lysyl oxidase enzymes involved in fibrosis and cancer. The company operates primarily in Australia while pursuing global partnerships for its clinical programs.
Financial Strength
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Cash-To-Debt | No Debt | |||||
Equity-to-Asset | 0.85 | |||||
Debt-to-EBITDA | -0.01 | |||||
Piotroski F-Score | 2/9 | |||||
WACC vs ROIC | ||||||
Growth Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year EBITDA Growth Rate | 28.6 | |||||
3-Year EPS without NRI Growth Rate | -38.7 | |||||
3-Year FCF Growth Rate | 34.9 | |||||
3-Year Book Growth Rate | -20.6 | |||||
Future 3-5Y EPS without NRI Growth Rate Estimate Industry Rank | 18.48 | |||||
Future 3-5Y Total Revenue Growth Rate Estimate | 22.12 |
Momentum Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
5-Day RSI | 70.43 | |||||
9-Day RSI | 62.27 | |||||
14-Day RSI | 57.4 | |||||
3-1 Month Momentum % | 16.67 | |||||
6-1 Month Momentum % | -4.55 | |||||
12-1 Month Momentum % | 5 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Current Ratio | 6.57 | |||||
Quick Ratio | 6.57 | |||||
Cash Ratio | 4.74 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | -43.6 | |||||
Shareholder Yield % | -4.64 |
Profitability Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
ROE % | -62.99 | |||||
ROA % | -49.39 | |||||
ROIC % | -875.18 | |||||
3-Year ROIIC % | -20.34 | |||||
ROC (Joel Greenblatt) % | -2819.18 | |||||
ROCE % | -66.88 | |||||
Years of Profitability over Past 10-Year | 1 |
GF Value Rank
4/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
PB Ratio | 2.56 | |||||
EV-to-EBIT | -3.16 | |||||
EV-to-Forward-EBIT | -0.6 | |||||
EV-to-EBITDA | -3.21 | |||||
EV-to-Forward-EBITDA | -0.61 | |||||
EV-to-Forward-Revenue | 2.18 | |||||
EV-to-FCF | -3.49 | |||||
Price-to-GF-Value | 0.55 | |||||
Earnings Yield (Greenblatt) % | -31.61 | |||||
FCF Yield % | -21.51 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Syntara Ltd Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil €) | |||
| EPS (TTM) (€) | -0.003 | ||
| Beta | 1.2049 | ||
| 3-Year Sharpe Ratio | 0.28 | ||
| 3-Year Sortino Ratio | 0.46 | ||
| Volatility % | 54.31 | ||
| 14-Day RSI | 57.4 | ||
| 14-Day ATR (€) | 0.0032 | ||
| 20-Day SMA (€) | 0.00995 | ||
| 12-1 Month Momentum % | 5 | ||
| 52-Week Range (€) | 0.0075 - 0.029 | ||
| Shares Outstanding (Mil) | 1,964.52 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 2 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Syntara Ltd Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Syntara Ltd Stock Events
| Event | Date | Price (€) | ||
|---|---|---|---|---|
| No Event Data | ||||
Syntara Ltd Frequently Asked Questions
What is Syntara Ltd(FRA:UUDA)'s stock price today?
The current price of FRA:UUDA is €0.01. The 52 week high of FRA:UUDA is €0.03 and 52 week low is €0.01.
When is next earnings date of Syntara Ltd(FRA:UUDA)?
The next earnings date of Syntara Ltd(FRA:UUDA) is .
Does Syntara Ltd(FRA:UUDA) pay dividends? If so, how much?
Syntara Ltd(FRA:UUDA) does not pay dividend.
Press Release
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers